DLD Asset Management, LP - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
DLD Asset Management, LP ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,722,000
-94.0%
10,000
-98.0%
0.13%
-91.1%
Q3 2018$28,528,000
+39.2%
498,300
+17.9%
1.41%
-8.6%
Q2 2018$20,494,000422,5061.54%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders